MLAB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MLAB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Mesa Laboratories's change in receivables for the quarter that ended in Sep. 2024 was $-4.0 Mil. It means Mesa Laboratories's Accounts Receivable increased by $4.0 Mil from Jun. 2024 to Sep. 2024 .
Mesa Laboratories's change in receivables for the fiscal year that ended in Mar. 2024 was $4.9 Mil. It means Mesa Laboratories's Accounts Receivable declined by $4.9 Mil from Mar. 2023 to Mar. 2024 .
Mesa Laboratories's Accounts Receivable for the quarter that ended in Sep. 2024 was $40.2 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mesa Laboratories's Days Sales Outstanding for the three months ended in Sep. 2024 was 63.48.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mesa Laboratories's liquidation value for the three months ended in Sep. 2024 was $-223.3 Mil.
The historical data trend for Mesa Laboratories's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories Annual Data | |||||||||||||||||||||
Trend | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | -1.67 | -0.65 | -6.75 | -2.12 | 4.94 |
Mesa Laboratories Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Change In Receivables | Get a 7-Day Free Trial | -1.01 | 2.85 | -3.35 | 3.48 | -4.05 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (NAS:MLAB) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Mesa Laboratories's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 40.234 | / | 57.833 | * | 91 |
= | 63.48 |
2. In Ben Graham's calculation of liquidation value, Mesa Laboratories's accounts receivable are only considered to be worth 75% of book value:
Mesa Laboratories's liquidation value for the quarter that ended in Sep. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 24.337 | - | 292.647 | + | 0.75 * 40.234 | + | 0.5 * 29.738 |
= | -223.3 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Mesa Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Gary M Owens | officer: COO | 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
Brian David Archbold | officer: SVP of Continuous Improvement | 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
John Bradley Schmieder | director | C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
John V Sakys | officer: VP Finance, CFO | MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
Shannon Hall | director | 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547 |
Evan Guillemin | director | 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003 |
R Tony Tripeny | director | ONE RIVERFRONT PLAZA, CORNING NY 14831 |
Gregory Dinoia | officer: SVP Commercial Operations | 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
Mesa Laboratories Inc /co/ | director | 12100 W 6TH AVE, LAKEWOOD CO 80228 |
John James Sullivan | officer: VP Sales & Marketing | 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
David M Kelly | director | |
Shiraz Shabanali Ladiwala | director | C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451 |
Robert V Dwyer | director | 12100 W 6TH AVE, LAKEWOOD CO 80228 |
Jennifer Sadie Alltoft | director | 12100 W. 6TH AVENUE, LAKEWOOD CO 80228 |
David Brian Perez | director | 12100 6TH AVENUE, LAKEWOOD CO 80228 |
From GuruFocus
By GuruFocus Research • 09-25-2024
By Stock market mentor Stock market mentor • 01-03-2023
By PRNewswire PRNewswire • 02-13-2023
By Marketwired • 07-08-2024
By GuruFocus News • 10-23-2024
By Marketwired • 06-21-2023
By Marketwired • 09-13-2023
By Marketwired • 08-03-2023
By GuruFocus Research • 09-15-2023
By Marketwired • 10-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.